Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 12NIH 6NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 52Leukemia, Myeloid, Acute 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma 23Burkitt Lymphoma 16Leukemia, Monocytic, Acute 15Leukemia, Myelomonocytic, Acute 14Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Congenital Abnormalities 12Leukemia, Biphenotypic, Acute 9Myelodysplastic Syndromes 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Eosinophilic, Acute 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Waldenstrom Macroglobulinemia 2Recurrence 2Neutropenia 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Tretinoin 2Methotrexate 2Mercaptopurine 2Gemtuzumab 2Flow Cytometry 2sargramostim 1Topotecan 1Microscopy 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Blotting, Western 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Promyelocytic, Acute × Cytarabine × Clear all
NCT00005962 2023-06-22

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Eastern Cooperative Oncology Group

Phase 2 Completed
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡